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Abstract: Alpha-glucosidase inhibitory activity has been commonly used for the evaluation of antidiabetic
property in vitro. The aim of this study is to investigate and characterize Dalbergia tonkinensis as a
potential source of antidiabetic compounds. The screening of the active parts used, such as trunk bark,
heartwood, and the leaves of Dalbergia tonkinensis indicated that all these extracted parts used with
methanol demonstrated potent α-glucosidase inhibitory activity. The in vitro antidiabetic property of
Dalbergia tonkinensis was notably recorded for the first time and showed activity (EC50 = 0.17–0.78 mg/mL)
comparable to those of reported potent herbal extracts (EC50 = 0.25–4.0 mg/mL) and higher activity
than that of acarbose, a commercial antidiabetic drug (EC50 = 1.21 mg/mL). The stability tests revealed
that the heartwood of Dalbergia tonkinensis extract (HDT) possesses high pH stability with relative
activity in the range of 80–98%. Further bioassay-guided purification led to the isolation of 2 active
compounds identified as sativanone and formononetin from the ethyl acetate fraction and water
fraction of HDT, respectively. These α-glucosidase inhibitors (aGIs) show promising inhibition against
various types of α-glucosidases. Remarkably, these inhibitors were determined as new mammalian
aGIs, showing good effect on rat α-glucosidase. The results suggest that Dalbergia tonkinensis is a
potent source of aGIs and suggest promise in being developed as functional food with antidiabetic
efficacy. The results of this study also enrich our knowledge concerning current biological activity
and constituents of Dalbergia tonkinensis species.
Keywords: diabetes; Dalbergia tonkinensis; sativanone; formononetin; heartwood; inhibitors
1. Introduction
Diabetes mellitus (DM), a major global health problem, has been quickly increasing, and has
reduced the life quality of people worldwide [1]. In 2013, the number of people living with DM was
reported to be 382 million; of these, 90% were affected by Type 2 diabetes and the estimated number of
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DM cases will reach 592 million by 2035 [2]. People affected by DM were reported to be at high risk of
various diseases, including kidney failure, cardiovascular disease, depression, frailty, premature death,
cognitive decline, and other diseases [1]. This disease has also been recognized as a major cause
of death, accounting for around 8.4% of total global deaths in 2013 [3]. Therefore, this issue is of
great interest to researchers worldwide. Several therapies for type 2 diabetes have been investigated.
Of these, the use of aGIs is considered to be an effective therapy for this global disease [4].
aGIs have been obtained from several sources, including chemical synthesis [5,6], herbs [7–9],
or microbial conversion of fishery by-products [10–13], nutrient broth [14,15], and fermented
soybeans [16–18]. Of these, herbal aGIs have received much attention for investigation due to their
nature and safety in type 2 diabetes management [7,8].
Vietnam, a tropical country has been considered as the sixteenth most biodiverse country with
more than 10,000 plant species. Of these, about 4000 species have been used as medicinal sources [19].
Therefore, there have been an increased interest in the screening and isolation of bioactive compounds
from herbs in recent years [7–9,20–22]; however, very few new records of antidiabetic herbs and
compounds have been reported from this biodiverse area [7,21]. Thus, the discovery of natural
products with beneficial properties from Vietnam has been received with great interest.
Dalbergia species are distributed in tropical and sub-tropical areas with more than 300 recognized
species [23,24]. This genus has been reported to possess numerous novel bioactivities, including:
anti-cancer, antimicrobial, anti-inflammatory, analgesic, anti-diarrheal, cardiovascular, spermicidal,
and antipyretic activities [24]. In particular, Dalbergia odorifera species has been extensively investigated
for its numerous chemical constituents and various reported biological activities, including α-glucosidase
inhibition [25]. In contrast, Dalbergia tonkinensis species, a medium-size floral species with a height
of 5–13 m and widely distributed in Vietnam [26], and found in Hainan Island of China [27] has been
poorly studied regarding its biological activities and chemical constituents. Some previous studies have
reported on the isolation and identification of various constituents from Dalbergia tonkinensis heartwood,
as well as its antimicrobial activity [26,28,29]. However, based on recent reviews, there has been no
report so far on the α-glucosidase inhibitory activity of this herb and its antidiabetic compounds.
In this study, Dalbergia tonkinensis was collected in the Dak Lak Province, Vietnam and its
heartwood was found to possess potent α-glucosidase inhibitory activity. Thus, this part was used in
conducting subsequent experiments on the isolation and identification of its active compounds. In the
current study, the specific inhibitory activity of isolated inhibitors was also tested for characterization
of their potential use in the management of type 2 diabetes.
2. Results and Discussion
2.1. New Records of Dalbergia tonkinensis Extracts as Potential Sources of aGIs
Dalbergia species has been considered as a valuable source of bioactive products, and the
heartwood of these herbs has been used in traditional Chinese medicines for the treatment of several
diseases, such as heart failure, myocardial fibrosis, myocardial infarction, myocarditis, and coronary
failure [24,25,30]. To evaluate Dalbergia tonkinensis as a source of antidiabetic drugs, the heartwood of
Dalbergia tonkinensis (HDT) was extracted with methanol; its inhibition against α-glucosidase was then
tested. The activity was calculated and expressed as EC50 value, which was defined as the concentration
of the sample (inhibitor) that inhibits 50% of enzymatic activity. Therefore, the lowest value that an
inhibitor gets, the greatest inhibitory activity it possesses. As shown in Table 1, HDT demonstrated
much stronger activity than that of acarbose, an antidiabetic drug with the EC50 values of 0.17 mg/mL
and 1.21 mg/mL, respectively. Recently, some herbs collected in Dak Lak Province were reported
as potential sources of aGIs [7–9,22]. Based on the summary presented in Table 1, HDT also showed
promising activity (EC50 = 0.17 mg/mL) compared to other reported herbs (EC50 = 0.25–4 mg/mL).
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Table 1. α-glucosidase inhibition of some potential extract of medicinal plants collected in Dak Lak.
No. Scientific Name of Medicinal Plants Part Used EC50 (mg/mL) References
1 Dalbergia tonkinensis Heartwood 0.17 ± 0.013 This study
Acabose (positive control) 1.21 ± 0.103
2 Terminalia alata Trunk bark ≥4 Nguyen et al., 2016 [8]
3 Terminalia bellirica Trunk bark 0.41 ± 0.03 Nguyen et al., 2016 [8]
4 Terminalia corticosa Trunk bark 1.42 ± 0.02 Nguyen et al., 2016 [8]
5 Euonymus laxiflorus Champ. Trunk bark 0.360 ± 0.03 Nguyen et al., 2017 [9]
6 Euonymus laxiflorus Champ. Leaves 0.67 Nguyen et al., 2017 [7]
7 Cinnamomum cassia J. S. Presl. Trunk bark 1.08 Nguyen et al., 2017 [7]
8 Terminalia bellirica Leaves 0.66 Nguyen et al., 2017 [7]
9 Psidium littorale Raddi Leaves 0.25 ± 0.01 Nguyen et al., 2018 [22]
All the samples were extracted with methanol as the method described in the material and method section;
their inhibition against α-glucosidase was tested and expressed as EC50 value.
To determine which part used is the most active, the heartwood, trunk bark, and leaves of
Dalbergia tonkinensis were collected and extracted with methanol; their activity was then tested.
As shown in Figure 1A, all the parts used of Dalbergia tonkinensis show stronger activity (98–100%) than
that of positive control (62%). These results highlighted the promising in vitro antidiabetic property of
the extracts from the heartwood, trunk bark and leaves of Dalbergia tonkinensis. To clarify the results,
the activity was also expressed as EC50 value. The heartwood extract demonstrated the strongest
activity among the Dalbergia tonkinensis parts used due to its smallest EC50 value of 0.17 mg/mL;
therefore, it was used in conducting subsequent experiments, including stability tests and purification.
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Figure 1. The inhibition of different Dalbergia tonkinensis parts used and expressed as aGI % (A) and 
EC50 values (B); results are means ± SD of multi tests (n = 3). 
2.2. The Stability of HDT Against Different pH Treatments 
It has been reported that a potential aGI should be stable under a wide range of pH readings, 
since the gastrointestinal tract is often acidic [7,10,14]. Thus, the pH stability of HDT was considered 
for testing in this study. As shown in Figure 2, the HDT showed its high pH stability with relative 
activity in the range of 80–98% after being treated with a large range of pH: 2–13. In the comparison, 
pH stability of HDT was higher than that of the methanol extract of Euonymus laxiflorus Champ 
possessing relative activity of 48–55% at pH 4–8 [7], comparable to that of fermented nutrient broth 
(78–98%) [14], and lower than that of fermented squid pens (89–150%) [10]. These results suggest 
that HDT may be a good candidate for aGIs due to its potent activity and high pH stability. 
Figure 1. The inhibition of different albergia tonkinensis parts used and expressed as aGI % (A) and
EC50 values (B); results are ea s SD of multi tests ( 3).
2.2. The Stability of HDT against Different pH Treatments
It has been reported that a potential a I should be stable under a wide range of pH readings,
since the gastrointesti al tract is ofte aci ic [7,10,14]. Thus, the pH stability of HDT was considered
for testing in this st . s s i i r 2, the HDT showed its high pH stability with relative
activity in the range of i t ith a large range of pH: 2–13. In the comparison,
pH stability of t t of the methanol extract of Euonymus laxiflorus Champ
po se sing relative acti it 4–8 [7], comparable to that of ermented nutrient broth
(78–98%) [ lower than that of fermented squid pens (89–150%) [10]. These results sugge t that
HDT may be a good candidate for aGIs due to its potent activity and high pH stability.
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Figure 2. The pH stability of HDT. The sample was treated in the range of pH 2–13 at 37 °C for 30 min. 
The α-glucosidase inhibitory activity was then tested and expressed as relative activity (%). Yeast 
α-glucosidase was used for the enzymatic inhibition assay. Results are means ± SD of multi tests (n = 
3). 
2.3. Isolation and Identification of Active Compounds from MeOH Extract of HDT 
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2.3.1. Primary Partitioned Separation of MeOH Extract of HDT 
The MeOH extract of HDT was successively partitioned with n-hexane, dichloromethane, ethyl 
acetate and water to obtain 4 fractions. The yield and activity of HDT and its fractions are recorded 
in Table 2. HDT-3 partitioned by ethyl acetate demonstrated the strongest activity due to its greatest 
inhibition (%) and lowest EC50 value of 95% and 0.069 mg/mL, respectively. Thus, this fraction was 
chosen for the isolation of active compounds. The water fraction (HDT-4) showed acceptable activity. 
Since it had the good profile of TLC separation, it was also considered for subsequent experiments of 
purification. 
Table 2. α-glucosidase inhibition of HDT and its fractions after partition. 
Samples  
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α-Glucosidase Inhibition 
EC50 (mg/mL) Inhibition (%) * 
HDT (crude MeOH extract) 60.3 0.172 ± 0.011 98 ± 3.2 
HDT-1 (Hexane Fr.) 1.6 1.712 ± 0.210 73 ± 4.1 
HDT-2 (Dichloromethane Fr.) 27.2 0.124 ± 0.003 90 ± 2.5 
HDT-3 (Ethyl acetate Fr.) 11.1 0.069 ± 0.001 95 ± 3.7 
HDT-4 (Water Fr.) 12.0 0.513 ± 0.051 82 ± 2.3 
Acarbose (positive control)  1.357 ± 0.03 62 ± 1.8 
*: the inhibition of acarbose and fractions were detected at their concentration range of 0.1–5 mg/mL; 
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Figure 2. The pH stability of HDT. The sample was treated in the rang of pH 2–13 at 37 ◦C for
30 min. The α-glucosidase inhibitory activity was t en tested and expressed as relative acti ity (%).
Yeast α-glucosidase was used for the enzymatic inhibition assay. Results are means ± SD of multi tests
(n = 3).
2.3. Isolation and Identification of Active Compounds from MeOH Extract of HDT
Various techniques, including solvent partition, silica open column chromatography (OPCC)
and preparative TLC, coupled with a bioassay were used to isolate the active co pounds from the
heartwood of Dalbergia tonkinensis. The general process of th se experiments is illustrated in Figure 3.
2.3.1. Primary Partitioned Separation of MeOH Extract of HDT
The MeOH extract of HDT was successively partitioned with n-hexane, dichloromethane,
ethyl acetate and water to obtain 4 fractions. The yield and activity of HDT and its fractions are
recorded in Table 2. HDT-3 partitioned by ethyl acetate demonstrated the strongest activity due to its
greatest inhibition (%) and lowest EC50 v lue of 95% and 0.069 mg/mL, respectively. Thus, this fraction
was chose for the isolation of active compounds. The water fraction (HDT-4) showed acceptable
activity. Since it had the good profile of TLC separation, it was also considered for subsequent
experiments of purification.
Table 2. α-glucosidase inhibition of HDT and its fractions after partition.
Samples Yield (g) α-Glucosidase Inhibition
EC50 (mg/mL) Inhibition (%) *
HDT (crude MeOH extract) 60.3 0.172 ± 0.011 98 ± 3.2
HDT-1 (Hexane Fr.) 1.6 1.712 ± 0.210 73 ± 4.1
HDT-2 (Dichloromethane Fr.) 27.2 0.124 ± 0.003 90 ± 2.5
HDT-3 (Ethyl acetate Fr.) 11.1 0.069 ± 0.001 95 ± 3.7
HDT-4 (Water Fr.) 12.0 0.513 ± 0.051 82 ± 2.3
Acarbose (positive control) 1.357 ± 0.03 62 ± 1.8
*: the inhibition of acarbose and fractions were detected at their concentration range of 0.1–5 mg/mL; results are
means ± SD of multi tests (n = 3).
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Figure 3. Flowchart for the isolation and identification of active inhibitors from the heartwood of
Dalbergia tonkinensis (HDT); Fr. (fraction).
2.3.2. Sub-fractionation of HDT-3 and HDT-4, and Identification of Active Compounds
The most active fraction (HDT-3) was separated by a silica open column to obtain 12 sub-fractions.
The activity of these sub-fractions was tested and expresse as %. As shown in Figure 4A, HDT-3.1
showed the b st activity (98%) while the others demon tr ted weak inhibition (2–36%) at same
tested concentration of 0.1 mg/mL. Further separation of HDT-3.1 was applied to the most active
sub-fraction (HDT-3.1.2), showing inhibition of 99% (Figure 4B).
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HDT-4 fraction was also separated by a silica open column: 8 sub-fractions were obtained,
their activity detected and then recorded in Figure 4C. T e sub-fraction (HDT-4.3) exhibited
good activity and a such was further separated via the same column. As shown in Figure 4D,
the sub-fraction (HDT-4.3.3) possessed highest activity (98.5%) among 6 sub-fractions of HDT-4.3.
For the two potent sub-fraction : HDT-3.1.2 and HDT-4.3.3, isolation of the active com ounds by
TLC was conducted. This final step of purification yielded 2 compounds: compound 1 (purified f om
HDT-3.1.2) and comp und 2 (purified fr m HDT-4.3.3). These 2 ctive compounds were identified
as sativanone (1) [31,32] and formononetin (2) [33,34], based on the analysis of NMR data and the
comparison with reported compounds. Notably, sativanone (1) and formononetin (2) de onstrated
much stronger activity than that of the positive control with the maximum activity and EC50 values of
90%, 0.23 mg/mL, 98 %, 0.059 mg/mL, and 62%, 1.321 mg/mL, respectively (Figure 4E).
Sativanone was reported to be distributed from the Restharrow root [35] and the heartwood
of Dalbergia odorifera and showed several bioactivities including antibacterial activity against
Ralstonia solanacearum [30] and anti-senescent and antioxidant effects [36]. This compound was also
reported to possibly possess yeastα-glucosidase inhibition by using ultra-filtration liquid chromatography/
mass spectrometry (UF-LC/MS) [37]. In this study, we strongly reconfirmed sativanone as a potent inhibitor
by isolating sativanone and then testing its inhibition against yeast α-glucosidase.
Formononetinis is a soy isoflavonoid that was isolated from several medicinal plants,
including Astragalus mongholicus (Bunge), Trifolium pretense L. (red clover), Butea monosperma [33],
Euchresta formosana [34], root and heartwood of Dalbergia odorifera [25]. Formononetin has also
bee reported to demonstrate some beneficial activities of yeast α-glucosidase inhibition, as well
as antibacteri l, antioxidant, anti-inflammatory, and cytotoxicity activities [25], to exhibit estrogenic
properties and to promote angiogen is [38].
The result highlight d th t thes efficient antidiabetic compounds were n wly is lated from
Dalbergia t nkinensis species a d pre-confirmed D lbergia tonkine sis’ value to be developed s a
health food due to its containing several bioactive compounds possessing vast beneficial bioactivities.
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In addition, the result of this study also enriches the current poor novel biological activities and
chemical constituents of Dalbergia tonkinensis species.
2.4. Specific Inhibitory Activity of the Purified Compounds
Specific inhibition of the purified compounds was detected to characterize them as active
antidiabetic drugs; a total of 4 enzymatic sources, including α-glucosidases from rat, yeast, bacterium,
and rice were conducted to test the inhibition. The activity was expressed as EC50 value and
presented in Table 3. The result indicated that sativanone showed efficient inhibition against bacterial
α-glucosidase, and good inhibition against α-glucosidases from yeast and rat but had a weak
effect on rice α-glucosidase. Formononetin also showed weak inhibition against rice α-glucosidase,
good inhibition against rat α-glucosidase, and a very efficient effect on α-glucosidases from yeast
and bacterium. Acarbose has the same ability of inhibition against rat and bacterial α-glucosidases as
sativanone and formononetin, but very weak inhibition against yeast α-glucosidase, while showing an
efficient effect on rice α-glucosidase.
Table 3. Specific inhibitory activity of Sativanone, Formononetin, and Acarbose.
No. Enzyme Source
Inhibition Expressed as EC50 (mg/mL)
Sativanone Formononetin Acarbose
1 Yeast α-glucosidase 0.23 ± 0.012 0.06 ± 0.002 1.321 ± 0.048
2 Rat α-glucosidase 0.37 ± 0.022 0.23 ± 0.037 0.121 ± 0.001
3 Bacterial α-glucosidase 0.07 ± 0.001 0.03 ± 0.002 0.001 ± 0.000
4 Rice α-glucosidase 0.81 ± 0.023 0.98 ± 0.029 0.031 ± 0.005
All tests were performed in triplicate; results are means ± SD of multi tests (n = 3).
Yeast α-glucosidase has been used as the target enzyme in the screening of in vitro antidiabetic
effect in many reports. However, α-glucosidase from rat was suggested as the better enzymatic source
for evaluation of potent inhibitors since this enzyme is closer to that of human [14]. In this study,
both sativanone and formononetin demonstrated much stronger inhibition against yeast α-glucosidase
than did acarbose, and showed their effects on rat α-glucosidase comparable to that of acarbose.
Thus, these two isolated compounds may be potential candidates for aGIs. In particular, the inhibitory
activity of sativanone and formononetin against rat α-glucosidase was newly investigated in the
current study, based on our current references review. Therefore, they were determined as new
mammalian aGIs.
2.5. The Rat α-Glucosidase Inhibitory Activity of Crude Extracts, Fractions, Sub-Fractions and Isolated
Compounds from Dalbergia Tonkinensis
All the parts used extracts (the heartwood, trunk bark, and leaves) of Dalbergia tonkinensis,
the fractions, sub-fractions, and purified compounds separated from HDT, as well as acarbose,
were tested their inhibition against α-glucosidase from rat. The results were expressed as EC50
and max inhibition then summarized in Table 4.
Among the 3 parts used extracts, HDT also demonstrated strongest inhibitory activity due to
its smallest EC50 and greatest inhibition values of 1.72 µg/mL, and 61%, respectively. The activity
was gradually increased via steps of partial purification. The 2 purified compounds showed their
much stronger activity than that of the crude sample (HDT) and its fractions (HDT-3, HDT-4),
and sub-fractions (HDT-3.1, HDT-3.1.2, HDT-4.3, and HDT-4.3.3). Based on Duncan’s multiple range
test, these are no significant difference among the EC50 values of 2 isolated inhibitors (sativanone and
formononetin) and that of acarbose as their EC50 values were ranged at fg, fg, and g level, respectively.
In additional, they showed their same potency max inhibition (91–94%), and all their max inhibition
values were ranked at the same level (a). Therefore, sativanone and formononetin were characterized
as potent rat aGIs such as acarbose, a commercial antidiabetic drug.
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Table 4. Rat α-glucosidase inhibitory activity of crude extracts, fractions, sub-fractions, and isolated
compounds from Dalbergia tonkinensis extract.
Components
Rat α-glucosidase Inhibitory Activity
EC50 (mg/mL) Max Inhibition (%)
Heartwood Extract (HDT) 1.72 ± 0.116 b 61 ± 3.46 e
Trunk bark extract 2.91 ± 0.289 a 51 ± 4.62 f
Leaves extract 2.78 ± 0.173 a 54 ± 4.60 f
HDT-3 1.31 ± 0.057 c 68 ± 5.77 d
HDT-3.1 1.13 ± 0.058 cd 75 ± 5.20 c
HDT-3.1.2 0.92 ± 0.023 d 77 ± 5.18 c
Sativanone 0.357 ± 0.006 fg 91 ± 4.61 a
HDT-4 1.43 ± 0.115 bc 67 ± 2.89 d
HDT-4.3 0.87 ± 0.035 de 78 ± 4.61 c
HDT-4.3.3 0.55 ± 0.012 ef 84 ± 4.62 b
Formononetin 0.251 ± 0.006 fg 94 ± 5.11 a
Acarbose 0.119 ± 0.005 g 93 ± 2.5 a
Coefficient of variation 12.50026 1.853018
The samples and acarbose were tested at their concentration range of 0.05–3.2 mg/mL; results are means ± SD of
multi tests (n = 3); the means of EC50 and max inhibition values with the different letter in the same column are
significantly different in comparison based on Duncan’s multiple range test (alpha = 0.01) using SAS version 9.4,
Statistical Analysis Software analysis.
3. Materials and Methods
3.1. Chemicals and Reagents
Rice α-glucosidase (Type 4) was purchased from Sigma Aldrich, St. Louis City, MO, USA.
Saccharomyces cerevisiae (yeast), B. stearothermophilus α-glucosidases and acarbose were obtained
from Sigma Chemical Co., St. Louis City, MO, USA. Rat α-glucosidase was provided by Sigma Aldrich,
Singapore. p-nitrophenyl glucopyranoside (pNPG) was purchased from Sigma Aldrich, 3050 Spruce
Street, St. Louis, MO, USA. 1H-NMR (500 MHz) and 13C-NMR (125 MHz) were measured on a Bruker
Avance 500 MHz spectrometer. Column chromatography was carried out on silica gel (Si 60 F254,
40–63 mesh, Merck, St. Louis, MO, USA). All solvents were redistilled before use. Pre-coated TLC
plates (Si 60 F254) were used for analytical purposes. Compounds were visualized under UV radiation
(254, 365 nm) and by spraying plates with 10% H2SO4, followed by heating with a heat gun.
3.2. Plant Materials
Trunk bark, leaves and heartwood of Dalbergia tonkinensis (over ten years old) was collected
in Buon Ma Thuot City, Daklak Province, Vietnam in 2016. The plant was identified by botanist
Dr. Nguyen Quoc Binh, Vietnam National Museum of Nature, VAST, Hanoi, Vietnam, using the Checklist
of plant species of Vietnam [39]. A voucher specimen (C-612) was deposited in the Department of
Bioactive Products, Institute of Natural Products Chemistry, VAST, Hanoi, Vietnam.
3.3. Purification Procedures and Identification of Major α-Glucosidase Inhibitors
Dried powdered heartwood (1.2 kg) of Dalbergia tonkinensis was extracted at 60 ◦C with
methanol (5 × 3.0 L) under reflux, filtered, and then concentrated under decreased pressure yielding
a black crude methanol residue (60.3 g). The suspension of the methanol residue in hot water was
successively partitioned with n-hexane, dichloromethane, and ethyl acetate to obtain n-hexane (1.6 g,
HDT-1), dichloromethane (27.2 g, HDT-2), ethyl acetate (11.1 g, HDT-3) and water (12.0 g, HDT-4)
fractions, respectively.
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The fraction HDT-3 (2.6 g) was chromatographed on a normal silica gel (40–63 mesh) chromatography
column (CC) using a gradient of n-hexane and acetone (99/1 to 0/1, v/v) as eluent to afford
12 sub-fractions (3.1–3.12). The sub-fraction 3.1 (500 mg) was rechromatographed on a normal silica gel
CC using a gradient of chloroform-acetone (30/2 to 20/3, v/v) as eluent to produce 8 sub-fractions
(3.1.1–3.1.8). The sub-fraction 3.1.2 (200 mg) was further separated by preparative TLC and eluting
with chloroform-ethyl acetate (11/3, v/v) to obtain compound 1 (10.0 mg).
The fraction HDT-4 (3.7 g) was chromatographed on a normal silica gel (40–63 mesh) chromatography
column (CC) using a gradient of chloroform-ethyl acetate (3/1 to 0/1, v/v) as eluent to afford
8 sub-fractions (4.1–4.8). The sub-fraction 4.3 (800 mg) was rechromatographed on a normal silica
gel CC using a gradient of chloroform-acetone (12/1 to 0/1, v/v) as eluent to produce 6 sub-fractions
(4.3.1–4.3.6). Compound 2 (8.0 mg) was obtained from the sub-fraction 4.3.3 (110 mg) by a normal
silica gel CC, eluting with chloroform-acetone (8/2).
Sativanone (1) was obtained as white amorphous powder; 1H-NMR (500 MHz, Acetone-d6)
δH: 9.40 (1H, br s, 7-OH), 7.77 (1H, d, J = 9.0 Hz, H-5), 7.01 (1H, d, J = 8.5 Hz, H-6′), 6.59 (1H, d,
J = 2.5 Hz, H-8), 6.58 (1H, dd, J = 9.0, 2.5 Hz, H-6), 6.48 (1H, dd, J = 8.5, 2.5 Hz, H-5′), 6.40 (1H, d,
J = 2.5 Hz, H-3′), 4.56 (1H, t, J = 11.0 Hz, Ha-2), 4.45 (1H, dd, J = 11.0, 5.5 Hz, Hb-2), 4.18 (1H, dd,
J = 11.0, 5.5 Hz, H-3), 3.79 (3H, s, 2′-OCH3), 3.78 (3H, s, 4′-OCH3). 13C-NMR (125 MHz, Acetone-d6) δC:
190.7 (s, C-4), 164.5 (s, C-7), 164.3 (s, C-8a), 161.1 (s, C-4′), 159.1 (s, C-2′), 131.2 (d, C-6′), 129.7 (d, C-5),
117.0 (s, C-1′), 110.8 (d, C-6), 105.3 (d, C-5′), 103.1 (d, C-3′), 99.2 (d, C-8), 71.4 (t, C-2), 55.6 (q, 4′-OCH3),
55.2 (q, 2′-OCH3), 47.6 (d, C-3).
Formononetin (2) was obtained as white amorphous powder; 1H-NMR (500 MHz, Methanol-d4)
δH: 8.17 (1H, s, H-2), 8.08 (1H, d, J = 8.5 Hz, H-5), 7.49 (2H, d, J = 8.5 Hz, H-2′, H-6′), 7.01 (2H, d,
J = 8.5 Hz, H-3′, H-5′), 6.97 (1H, dd, J = 8.5, 2.0 Hz, H-6), 6.88 (1H, d, J = 2.0 Hz, H-8), 3.85 (3H, s,
4′-OCH3); 13C-NMR (125 MHz, Methanol-d4): 178.1 (s, C-4), 164.9 (s, C-7), 161.1 (s, C- C-4′), 159.8 (s,
C-8a), 154.8 (d, C-2), 131.4 (d, C-2′, C-6′), 128.5 (d, C-5), 125.7 (s, C-3), 125.6 (s, C-1′), 118.1 (s, C-4a),
116.6 (d, C-6), 114.9 (d, C-3′, C-5′), 103.3 (d, C-8), 55.7 (q, 4′-OCH3).
3.4. Enzymatic Inhibitory Assays
The inhibitory activity against α-glucosidases was done according to the assay described by
Nguyen, et al. 2018 [15]. The mixture of 50 µL of the sample, 50 µL of the α-glucosidase solution
and 100 µL potassium phosphate buffer was pre-incubated at 37 ◦C for 20 min for the combination
of inhibitors with enzymes. 50 µL of substrate (pNPG) was added into the mixture to start the
reaction. This reaction step was maintained at 37 ◦C for 30 min for the detection of inhibition against
α-glucosidases from rice, yeast, and bacteria, and for 60 min when rat α-glucosidases was used
instead. Thereafter, the mixture solution’s optical density was detected at 405 nm (the wavelength).
The following formula was used to calculate the α-glucosidase inhibitory activity:
aGI (%) = (A − B)/A × 100%, (1)
where aGI is α-glucosidase inhibitory activity, A and B are the optical density of the reaction mixture
without sample (inhibitor) and the reaction mixture presenting sample, respectively, at the wavelength
405nm. The concentration of inhibitor that inhibits 50% of activity of α-glucosidase under the assay
conditions was defined as the EC50 value. Potassium phosphate buffer (0.1 mol/L, pH 7) was used for
the preparation of the enzymes, substrate, and sample solutions. The rat α-glucosidase solution was
prepared according to the previous report [14]. Bacterial, yeast and rice glucosidases were tested at the
concentrations of 1.0, 0.25, and 0.1 U/mL, respectively.
4. Conclusions
The methanol extracts of all the parts of Dalbergia tonkinensis used, including heartwood,
trunk bark, and leaves, were found to be potential sources of α-glucosidase inhibitors (aGIs),
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showing more efficient inhibitory activity than that of acarbose. The 2 active inhibitors were
successfully isolated and identified from the heartwood of Dalbergia tonkinensis. Notably, these active
compounds, sativanone and formononetin demonstrated much stronger activity than that of acarbose.
The specific inhibitory activity tests showed that sativanone and formononetin also have good
effects on mammalian α-glucosidase; this property of these inhibitors was newly investigated in
this study. The results highlight that Dalbergia tonkinensis is a valuable source of aGIs and could be
developed as a health food due to it containing several compounds possessing various beneficial
bioactivities. These results also enrich the current poor understanding of the novel biological activities
and constituents of Dalbergia tonkinensis species. However, the mechanism of enzyme inhibition of
the active compounds described here is still unknown, as such it will be important to investigate in
further studies.
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